Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Moreau, JL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ouagazzal, AM; Grottick, AJ; Moreau, JL; Higgins, GA
      Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains

      NEUROPSYCHOPHARMACOLOGY
    2. Dautzenberg, FM; Kilpatrick, GJ; Hauger, RL; Moreau, JL
      Molecular biology of the CRH receptors - in the mood

      PEPTIDES
    3. Weiss, IC; Domeney, AM; Moreau, JL; Russig, H; Feldon, J
      Dissociation between the effects of pre-weaning and/or post-weaning socialisolation on prepulse inhibition and latent inhibition in adult Sprague-Dawley rats

      BEHAVIOURAL BRAIN RESEARCH
    4. Eckenberg, R; Rose, T; Moreau, JL; Weil, R; Gesbert, F; Dubois, S; Tello, D; Bossus, M; Gras, H; Tartar, A; Bertoglio, J; Chouaib, S; Jacques, Y; Alzari, PM; Theze, J
      Characterization of an IL-2 mimetic with therapeutic potential

      CELLULAR AND MOLECULAR BIOLOGY
    5. Weiss, IC; Domeney, AM; Heidbreder, CA; Moreau, JL; Feldon, J
      Early social isolation, but not maternal separation, affects behavioral sensitization to amphetamine in male and female adult rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    6. Ouagazzal, AM; Jenck, F; Moreau, JL
      Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

      PSYCHOPHARMACOLOGY
    7. Jenck, F; Ouagazzal, AM; Pauly-Evers, M; Moreau, JL
      OrphaninFQ: role in behavioral fear responses and vulnerability to stress?

      MOLECULAR PSYCHIATRY
    8. Le Pen, G; Grottick, AJ; Higgins, GA; Martin, JR; Jenck, F; Moreau, JL
      Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia

      BEHAVIOURAL PHARMACOLOGY
    9. Lee, M; O'regan, S; Moreau, JL; Johnson, AL; Johnston, LH; Goding, CR
      Regulation of the Pcl7-Pho85 cyclin-cdk complex by Pho81

      MOLECULAR MICROBIOLOGY
    10. Kew, JNC; Koester, A; Moreau, JL; Jenck, F; Ouagazzal, AM; Mutel, V; Richards, JG; Trube, G; Fischer, G; Montkowski, A; Hundt, W; Reinscheid, RK; Pauly-Evers, M; Kemp, JA; Bluethmann, H
      Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site

      JOURNAL OF NEUROSCIENCE
    11. Jenck, F; Wichmann, J; Dautzenberg, FM; Moreau, JL; Ouagazzal, AM; Martin, JR; Lundstrom, K; Cesura, AM; Poli, SM; Roever, S; Kolczewski, S; Adam, G; Kilpatrick, G
      A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    12. Riquet, M; Porte, H; Chapelier, A; Brichon, PY; Bernard, A; Dujon, A; Dahan, M; Bonette, P; Guidicelli, R; Jancovici, R; Monteau, M; Moreau, JL; Moreau, JM; Peillon, C; Bellenot, F; Faillon, JM; Mouroux, J
      Resection of lung cancer invading the diaphragm

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    13. Eckenberg, R; Moreau, JL; Melnyk, O; Theze, J
      IL-2R beta agonist p1-30 acts in synergy with IL-2, IL-4, IL-9, and IL-15:Biological and molecular effects

      JOURNAL OF IMMUNOLOGY
    14. Eckenberg, R; Rose, T; Moreau, JL; Weil, R; Gesbert, F; Dubois, S; Tello, D; Bossus, M; Gras, H; Tartar, A; Bertoglio, J; Chouaib, S; Goldberg, M; Jacques, Y; Alzari, PM; Theze, J
      The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells

      JOURNAL OF EXPERIMENTAL MEDICINE
    15. Stout, SC; Mortas, P; Owens, MJ; Nemeroff, CB; Moreau, JL
      Increased corticotropin-releasing factor concentrations in the bed nucleusof the stria terminalis of anhedonic rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Marques, F; Moreau, JL; Peaucellier, G; Lozano, JC; Schatt, P; Picard, A; Callebaut, I; Perret, E; Geneviere, AM
      A new subfamily of high molecular mass CDC2-related kinases with PITAI/VREmotifs

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Jenck, F; Moreau, JL; Wichmann, J; Stadler, H; Martin, JR; Bos, M
      Brain 5-HT2C receptors: Potential role in anxiety disorders

      ANXIOLOYTICS
    18. Jenck, F; Martin, JR; Moreau, JL
      The 5-HT1A receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats

      JOURNAL OF PSYCHOPHARMACOLOGY
    19. Moreau, JL; Huber, G
      Central adenosine A(2A) receptors: an overview

      BRAIN RESEARCH REVIEWS
    20. Koster, A; Montkowski, A; Schulz, S; Stube, EM; Knaudt, K; Jenck, F; Moreau, JL; Nothacker, HP; Civelli, O; Reinscheid, RK
      Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    21. Herblot, S; Chastagner, P; Samady, L; Moreau, JL; Demaison, C; Froussard, P; Liu, XY; Bonnet, J; Theze, J
      IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control

      JOURNAL OF IMMUNOLOGY
    22. HERBLOT S; CHASTAGNER P; SAMADY L; MOREAU JL; DEMAISON C; FROUSSARD P; LIU X; BONNET J; THEZE J
      IL-2 DEPENDENT EXPRESSION OF GENES INVOLVED IN CYTOSKELETON ORGANIZATION, ONCOGENE REGULATION AND TRANSCRIPTIONAL CONTROL

      European cytokine network
    23. BANI L; DAVID D; FEVRIER M; MOREAU JL; CAYOTA A; NAKARAI T; SUGAMURA K; RITZ J; THEZE J
      INTERLEUKIN-2 GAMMA-CHAIN - INTRACELLULAR EXPRESSION ON RESTING CD4 T-CELLS AND DYSREGULATION BY HIV-1 GP120 IN ACTIVATED CD4 T-LYMPHOCYTES

      European cytokine network
    24. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      IMPACT OF TRIPLE COMBINATION THERAPY ON THE IL-2 REACTIVITY OF CD4 AND CD8 T-LYMPHOCYTES FROM HIV-INFECTED PATIENTS

      European cytokine network
    25. ECKENBERG R; ROSE T; MOREAU JL; WEIL R; GESBERT F; BERTOGLIO J; JACQUES Y; BOSSUS M; GRAS H; TARTAR A; GOLDBERG M; ALZARI P; THEZE J
      PEPTIDE AGONIST OF THE IL-2 RECEPTOR-BETA CHAIN

      European cytokine network
    26. DAVID D; BANI L; MOREAU JL; TREILHOU MP; DEMAISON C; SUN K; FEVRIER M; SALVUCCI O; CAYOTA A; NAKARAI T; CHOUAIB S; DEMONTALEMBERT M; JOUSSEMET M; SUGAMURA K; RITZ J; DUPONT B; PIALOUX G; THEZE J
      DYSREGULATION OF INTERLEUKIN-2 RECEPTOR-BETA AND INTERLEUKIN-2 RECEPTOR-GAMMA EXPRESSION DURING HIV INFECTION

      European cytokine network
    27. JENCK F; MOREAU JL; BERENDSEN HHG; BEES M; BROEKKAMP CLE; MARTIN JR; WICHMANN J; VANDELFT AML
      ANTIAVERSIVE EFFECTS OF 5HT(2C) RECEPTOR AGONISTS AND FLUOXETINE IN AMODEL OF PANIC-LIKE ANXIETY IN RATS

      European neuropsychopharmacology
    28. SPERBER GH; MOREAU JL
      STUDY OF THE NUMBER OF ROOTS AND CANALS IN SENEGALESE FIRST PERMANENTMANDIBULAR MOLARS

      International endodontic journal
    29. MARTIN JR; MOREAU JL; JENCK F; PIERI L
      SARMAZENIL-PRECIPITATED WITHDRAWAL - A RELIABLE METHOD FOR ASSESSING DEPENDENCE LIABILITY OF BENZODIAZEPINE RECEPTOR LIGANDS

      Pharmacology, biochemistry and behavior
    30. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      REGULATORY DYSFUNCTION OF THE INTERLEUKIN-2 RECEPTOR DURING HIV-INFECTION AND THE IMPACT OF TRIPLE COMBINATION THERAPY

      Proceedings of the National Academy of Sciences of the United Statesof America
    31. MARTIN JR; BOS M; JENCK F; MOREAU JL; MUTEL V; SLEIGHT AJ; WICHMANN J; ANDREWS JS; BERENDSEN HHG; BROEKKAMP CLE; RUIGT GSF; KOHLER C; VANDELFT AML
      5-HT2C RECEPTOR AGONISTS - PHARMACOLOGICAL CHARACTERISTICS AND THERAPEUTIC POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    32. BOS M; STADLER H; WICHMANN J; JENCK F; MARTIN JR; MOREAU JL; SLEIGHT AJ
      SYNTHESES OF O-METHYLASPARVENONE-DERIVED SEROTONIN-RECEPTOR ANTAGONISTS

      Helvetica Chimica Acta
    33. MOREAU JL; MARQUES F; BARAKAT A; SCHATT P; LOZANO JC; PEAUCELLIER G; PICARD A; GENEVIERE AM
      CDK2 ACTIVITY IS DISPENSABLE FOR THE ONSET OF DNA-REPLICATION DURING THE FIRST MITOTIC-CYCLES OF THE SEA-URCHIN EARLY EMBRYO

      Developmental biology (Print)
    34. DAVID D; BANI L; MOREAU JL; THEZE J
      INTERLEUKIN-2 RECEPTOR SUBUNIT EXPRESSION AND FUNCTION ON HUMAN PERIPHERAL T-CELLS IS NOT DEPENDENT ON THE ANTICOAGULANT - RESPONSE

      Blood
    35. DAVID D; BANI L; MOREAU JL; DEMAISON C; SUN K; SALVUCCI O; NAKARAI T; DEMONTALEMBERT M; CHOUAIB S; JOUSSEMET M; RITZ J; THEZE J
      FURTHER ANALYSIS OF INTERLEUKIN-2 RECEPTOR SUBUNIT EXPRESSION ON THE DIFFERENT HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL SUBSETS

      Blood
    36. SARAGOVI HU; BHANDOOLA A; MOREAU JL; LAVINE N; GAGNON M; LEMERCIER MM; THEZE J
      FUNCTIONAL AND PHYSICAL ASSOCIATION OF A CELL-SURFACE PHOSPHOLIPID AND INTERLEUKIN-2 RECEPTOR P55(ALPHA) SUBUNITS

      Biochimica et biophysica acta. Biomembranes
    37. ECKENBERG R; XU D; MOREAU JL; BOSSUS M; MAZIE JC; TARTAR A; LIU XY; ALZARI PM; BERTOGLIO J; THEZE J
      ANALYSIS OF HUMAN IL-2 IL-2 RECEPTOR-BETA CHAIN INTERACTIONS - MONOCLONAL-ANTIBODY H2-8 AND NEW IL-2 MUTANTS DEFINE THE CRITICAL ROLE OF ALPHA-HELIX-A OF IL-2

      Cytokine
    38. MOREAU JL; KILPATRICK G; JENCK F
      UROCORTIN, A NOVEL NEUROPEPTIDE WITH ANXIOGENIC-LIKE PROPERTIES

      NeuroReport
    39. BANI L; DAVID D; MOREAU JL; CAYOTA A; NAKARAI T; RITZ J; THEZE J
      EXPRESSION OF THE IL-2 RECEPTOR-GAMMA SUBUNIT IN RESTING HUMAN CD4 T-LYMPHOCYTES - MESSENGER-RNA IS CONSTITUTIVELY TRANSCRIBED AND THE PROTEIN STORED AS AN INTRACELLULAR COMPONENT

      International immunology
    40. BOS M; JENCK F; MARTIN JR; MOREAU JL; MUTEL V; SLEIGHT AJ; WIDMER U
      SYNTHESIS, PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF 10-METHOXYPYRAZINO[1,2-A]INDOLES, PARTIAL AGONISTS AT THE 5HT(2C) RECEPTOR

      European journal of medicinal chemistry
    41. THEZE J; BANI L; DAVID D; MOREAU JL; CAYOTA A; NAKARAI T; RITZ J
      EXPRESSION OF THE IL-2 RECEPTOR-GAMMA SUBUNIT IN HUMAN CD4 T-LYMPHOCYTES

      Journal of allergy and clinical immunology
    42. GOTTOWIK J; GOETSCHY V; HENRIOT S; KITAS E; FLUHMAN B; CLERC RG; MOREAU JL; MONSMA FJ; KILPATRICK GJ
      LABELING OF CRF1 AND CRF2 RECEPTORS USING THE NOVEL RADIOLIGAND, [H-3] UROCORTIN

      Neuropharmacology
    43. JENCK F; MOREAU JL; MARTIN JR; KILPATRICK GJ; REINSCHEID RK; MONSMA FJ; NOTHACKER HP; CIVELLI O
      ORPHANIN FQ ACTS AS AN ANXIOLYTIC TO ATTENUATE BEHAVIORAL-RESPONSES TO STRESS

      Proceedings of the National Academy of Sciences of the United Statesof America
    44. BOS M; JENCK F; MARTIN JR; MOREAU JL; SLEIGHT AJ; WICHMANN J; WIDMER U
      NOVEL AGONISTS OF 5HT(2C) RECEPTORS - SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED 2-(INDOL-1-YL)-1-METHYLETHYLAMINES AND 2-(INDENO[1,2-B]PYRROL-1-YL)-1-METHYLETHYLAMINES - IMPROVED THERAPEUTICS FOR OBSESSIVE-COMPULSIVE DISORDER

      Journal of medicinal chemistry
    45. MOREAU JL
      RELIABLE MONITORING OF HEDONIC DEFICITS IN THE CHRONIC MILD STRESS MODEL OF DEPRESSION

      Psychopharmacology
    46. DEMAISON C; CHASTAGNER P; MOREAU JL; THEZE J
      LIGAND-INDUCED AUTOREGULATION OF IL-2 RECEPTOR-ALPHA CHAIN EXPRESSIONIN MURINE T-CELL LINES

      International immunology
    47. JENCK F; MARTIN JR; MOREAU JL
      BEHAVIORAL-EFFECTS OF CCKB RECEPTOR LIGANDS IN A VALIDATED SIMULATIONOF PANIC ANXIETY IN RATS

      European neuropsychopharmacology
    48. MOREAU JL; BOS M; JENCK F; MARTIN JR; MORTAS P; WICHMANN J
      5HT(2C) RECEPTOR AGONISTS EXHIBIT ANTIDEPRESSANT-LIKE PROPERTIES IN THE ANHEDONIA MODEL OF DEPRESSION IN RATS

      European neuropsychopharmacology
    49. BANI L; MOREAU JL; DAVID D; DEMAISON C; SUN K; NAKARAI T; SALUUCCI O; CHOUAIB S; RITZ J; THEZE J
      EVIDENCE FOR DIFFERENTIAL EXPRESSION OF THE BETA-SUBUNITS AND GAMMA-SUBUNITS OF THE IL-2 RECEPTOR IN HUMAN LYMPHOMONONUCLEAR CELLS

      The FASEB journal
    50. CHEFCHAOUNI MC; FLAM T; CORNUD F; THIOUNN N; BELIN X; DESLIGNERES S; ZERBIB M; MOREAU JL; DEBRE B
      ENDORECTAL MRI FOR LOCAL STAGING OF PROST ATE-CANCER - CORRELATION WITH PATHOLOGY SPECIMENS - A REPORT OF 37 CASES

      Journal d'urologie
    51. WILLNER P; MOREAU JL; NIELSEN CK; PAPP M; SLUZEWSKA A
      DECREASED HEDONIC RESPONSIVENESS FOLLOWING CHRONIC MILD STRESS IS NOTSECONDARY TO LOSS OF BODY-WEIGHT

      Physiology & behavior
    52. LUNDKVIST J; CHAI Z; TEHERANIAN R; HASANVAN H; BARTFAI T; JENCK F; WIDMER U; MOREAU JL
      A NON PEPTIDIC CORTICOTROPIN-RELEASING FACTOR-RECEPTOR ANTAGONIST ATTENUATES FEVER AND EXHIBITS ANXIOLYTIC-LIKE ACTIVITY

      European journal of pharmacology
    53. SALVUCCI O; MAMICHOUAIB F; MOREAU JL; THEZE J; CHEHIMI J; CHOUAIB S
      DIFFERENTIAL REGULATION OF INTERLEUKIN-12-INDUCED AND INTERLEUKIN-15-INDUCED NATURAL-KILLER-CELL ACTIVATION BY INTERLEUKIN-4

      European Journal of Immunology
    54. CHASTAGNER P; MOREAU JL; JACQUES Y; MIYASAKA M; KONDO M; SUGAMURA K; THEZE J
      LACK OF INTERMEDIATE-AFFINITY INTERLEUKIN-2 RECEPTOR IN MICE LEADS TODEPENDENCE ON INTERLEUKIN-2-RECEPTOR-ALPHA, INTERLEUKIN-2-RECEPTOR-BETA-AND-GAMMA CHAIN EXPRESSION FOR T-CELL GROWTH

      European Journal of Immunology
    55. BERNARD A; AZORIN J; BELLENOT F; BONNETTE P; BRICHON PY; BRUTUS P; CHAPELIER A; CHARPENTIER R; DAHAN M; DUJON A; ESCANDE G; FAILLON MJ; GIUDICELLI R; GROSDIDIER G; GRUNENWALD D; JANCOVICI R; JOYEUX A; MERIOT S; MONTEAU M; MOREAU JL; MOREAU P; MOUROUX J; POULIQUEN E; RAUT Y; REGNARD JF; RIQUET M; VALVERDE JP; VELLY JF; WILHM JM
      RESECTION OF PULMONARY NODULES USING VIDEO-ASSISTED THORACIC-SURGERY

      The Annals of thoracic surgery
    56. XU D; ECKENBERG R; MOREAU JL; LIU XY; THEZE J; BERTOGLIO J
      BIOLOGICAL AND RECEPTOR-BINDING ACTIVITIES OF HUMAN INTERLEUKIN-2 MUTATED AT RESIDUES 20ASP, 125CYS OR 127SER

      European cytokine network
    57. MARTIN JR; MOREAU JL; JENCK F
      ANIRACETAM REVERSES MEMORY IMPAIRMENT IN RATS

      Pharmacological research
    58. MOREAU JL; SCHERSCHLICHT R; JENCK F; MARTIN JR
      CHRONIC MILD STRESS-INDUCED ANHEDONIA MODEL OF DEPRESSION - SLEEP ABNORMALITIES AND CURATIVE EFFECTS OF ELECTROSHOCK TREATMENT

      Behavioural pharmacology
    59. CHASTAGNER P; MOREAU JL; MIYASAKA M; SUGAMURA K; THEZE J
      INTERLEUKIN-2 RECEPTOR - CRITICAL ROLE OF THE ALPHA-CHAIN (P55) IN THE CONTROL OF SIGNAL-TRANSDUCTION AND CELL-GROWTH IN MURINE AND HUMAN T-CELLS

      The FASEB journal
    60. MARTIN JR; MOREAU JL; JENCK F
      EVALUATION OF THE DEPENDENCE LIABILITY OF QUINOLIZINONES ACTING AS PARTIAL AGONISTS AT THE BENZODIAZEPINE RECEPTOR

      Drug development research
    61. JENCK F; MOREAU JL; MARTIN JR
      DORSAL PERIAQUEDUCTAL GRAY-INDUCED AVERSION AS A SIMULATION OF PANIC ANXIETY - ELEMENTS OF FACE AND PREDICTIVE-VALIDITY

      Psychiatry research
    62. MOREAU JL; BOSSUS M; DEGROOTE D; FRANCOIS C; JACQUES Y; TARTAR A; THEZE J
      CHARACTERIZATION OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE NH2 TERMINAL AREA OF INTERLEUKIN-2 (IL-2) AND INHIBITING SPECIFICALLY THE BINDING OF IL-2 TO IL-2 RECEPTOR-BETA CHAIN (IL-2R-BETA)

      Molecular immunology
    63. MARTIN JR; JENCK F; MOREAU JL
      COMPARISON OF BENZODIAZEPINE RECEPTOR LIGANDS WITH PARTIAL AGONISTIC,ANTAGONISTIC OR PARTIAL INVERSE AGONISTIC PROPERTIES IN PRECIPITATINGWITHDRAWAL IN SQUIRREL-MONKEYS

      The Journal of pharmacology and experimental therapeutics
    64. MOREAU JL; CHASTAGNER P; TANAKA T; MIYASAKA M; KONDO M; SUGAMURA K; THEZE J
      CONTROL OF THE IL-2 RESPONSIVENESS OF B-LYMPHOCYTES BY IL-2 AND IL-4

      The Journal of immunology
    65. GENEVIEREGARRIGUES AM; BARAKAT A; DOREE M; MOREAU JL; PICARD A
      ACTIVE CYCLIN B-CDC2 KINASE DOES NOT INHIBIT DNA-REPLICATION AND CANNOT DRIVE PREMATURELY FERTILIZED SEA-URCHIN EGGS INTO MITOSIS

      Journal of Cell Science
    66. MARTIN JR; MOREAU JL; JENCK F
      PRECIPITATED WITHDRAWAL IN SQUIRREL-MONKEYS AFTER REPEATED DAILY ORAL-ADMINISTRATION OF ALPRAZOLAM, DIAZEPAM, FLUNITRAZEPAM OR OXAZEPAM

      Psychopharmacology
    67. MOREAU JL; AZZA S; BIGEY F; ARNAUD A; GALZY P
      APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TO THE STUDY OFTHE BIOLOGICAL TRANSFORMATION OF ADIPONITRILE

      Journal of chromatography B. Biomedical applications
    68. MOREAU JL; BOURSON A; JENCK F; MARTIN JR; MORTAS P
      CURATIVE EFFECTS OF THE ATYPICAL ANTIDEPRESSANT MIANSERIN IN THE CHRONIC MILD STRESS-INDUCED ANHEDONIA MODEL OF DEPRESSION

      Journal of psychiatry & neuroscience
    69. GRIEBEL G; MOREAU JL; JENCK F; MUTEL V; MARTIN JR; MISSLIN R
      EVIDENCE THAT TOLERANCE TO THE ANXIOGENIC-LIKE EFFECTS OF MCPP DOES NOT INVOLVE ALTERATION IN THE FUNCTION OF 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS

      Behavioural pharmacology
    70. MOREAU JL; BORGULYA J; JENCK F; MARTIN JR
      TOLCAPONE - A POTENTIAL NEW ANTIDEPRESSANT DETECTED IN A NOVEL ANIMAL-MODEL OF DEPRESSION

      Behavioural pharmacology
    71. MOREAU JL; ARNAUD A; GALZY P
      OPTIMIZATION OF CULTURE CONDITIONS OF BREVIBACTERIUM SP FOR THE PRODUCTION OF AMIDASE AND ADIPAMIDASE

      Microbiological research
    72. MOREAU JL; BIGEY F; AZZA S; ARNAUD A; GALZY P
      THE ENZYMATIC PRODUCTION OF ADIPIC ACID

      Biocatalysis
    73. JENCK F; MOREAU JL; MUTEL V; MARTIN JR
      BRAIN 5-HT1C RECEPTORS AND ANTIDEPRESSANTS

      Progress in neuro-psychopharmacology & biological psychiatry
    74. GRIEBEL G; MOREAU JL; JENCK F; MISSLIN R; MARTIN JR
      ACUTE AND CHRONIC TREATMENT WITH 5-HT REUPTAKE INHIBITORS - DIFFERENTIALLY MODULATE EMOTIONAL RESPONSES IN ANXIETY MODELS IN RODENTS

      Psychopharmacology
    75. FRANCOIS J; MOREAU JL; MUTEL V; MARTIN JR
      DEPRESSION, CHRONIC MILD STRESS AND BRAIN 5-HT(1C) RECEPTORS

      Neuropsychopharmacology
    76. GRIEBEL G; MOREAU JL; JENCK F; MARTIN JR; MISSLIN R
      SOME CRITICAL DETERMINANTS OF THE BEHAVIOR OF RATS IN THE ELEVATED PLUS-MAZE

      Behavioural processes
    77. HAEFELY W; BURKARD WP; CESURA A; COLZI A; KETTLER R; LOREZ HP; MARTIN JR; MOREAU JL; RICHARDS JG; SCHAFFNER R; SCHERSCHLICHT R; SEPINWALL J; DAPRADA M
      PHARMACOLOGY OF MOCLOBEMIDE

      Clinical neuropharmacology
    78. MOREAU JL; AZZA S; ARNAUD A; GALZY P
      PURIFICATION AND CHARACTERIZATION OF NITRILE HYDRATASE OF A MUTANT STRAIN OF BREVIBACTERIUM SP

      Journal of basic microbiology
    79. MARTIN JR; MOREAU JL; JENCK F; CUMIN R
      ACUTE AND CHRONIC ADMINISTRATION OF BUSPIRONE FAILS TO YIELD ANXIOLYTIC-LIKE EFFECTS IN A MOUSE OPERANT PUNISHMENT PARADIGM

      Pharmacology, biochemistry and behavior
    80. MOREAU JL; BERNET N; ARNAUD A; GALZY P
      ISOLATION OF BREVIBACTERIUM SP R312 MUTANTS POTENTIALLY USEFUL FOR THE ENZYMATIC PRODUCTION OF ADIPIC ACID

      Canadian journal of microbiology
    81. AZZA S; MOREAU JL; CHEBROU H; ARNAUD A; GALZY P
      N-TERMINAL AMINO-ACID-SEQUENCE OF MUTANT STRAIN BREVIBACTERIUM SP ADIPAMIDASE

      Antonie van Leeuwenhoek
    82. MARTIN JR; SCHOCH P; JENCK F; MOREAU JL; HAEFELY WE
      PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE RECEPTOR LIGANDS WITH INTRINSIC EFFICACIES RANGING FROM HIGH TO ZERO

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:50:35